Bass, Berry & Sims served as lead counsel to Acadia Healthcare Company, Inc. in its efforts to obtain a Certificate of Need (CON) to open a state-of-the-art opioid treatment program (OTP) facility in Cleveland, Tennessee. OTPs use medication-assisted treatment and therapeutic interventions to help individuals overcome their struggles with addiction and are considered the “gold standard” for addiction recovery. Despite opposition from other providers, the project was unanimously approved by state regulators.
Acadia Healthcare (Nasdaq: ACHC) is a leading provider of behavioral healthcare services. As of September 30, 2020, Acadia operated a network of 582 behavioral healthcare facilities with approximately 18,300 beds in 40 states, Puerto Rico and the United Kingdom. Acadia provides behavioral healthcare and substance use services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.